| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,704 |
6,866 |
$332K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,831 |
1,729 |
$115K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
418 |
409 |
$27K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
446 |
433 |
$25K |
| T1015 |
Clinic visit/encounter, all-inclusive |
163 |
123 |
$23K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
119 |
86 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
594 |
528 |
$17K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,043 |
991 |
$9K |
| 87428 |
|
139 |
134 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
859 |
842 |
$5K |
| 99051 |
|
72 |
70 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
71 |
71 |
$674.96 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$281.52 |
| 82962 |
|
122 |
116 |
$192.29 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
16 |
$121.20 |
| 96127 |
|
27 |
27 |
$64.79 |
| 90686 |
|
13 |
13 |
$0.60 |